A Randomized Trial of Everolimus Initiation and Calcineurin Inhibitor (CNI) Elimination in Stable Heart Transplant Recipients With Impaired Renal Function
Derthoo, D.; Van Caenegem, O.; De Pauw, M.; Nellessen, E.; Duerinckx, N.; Ciarka, A.; Droogné, W.; Van Cleemput, J.; Belmans, A.; Meyns, B.; Vanhaecke, J.
Journal of Heart and Lung Transplantation 33(4): S14-S15
2014
ISSN/ISBN: 1053-2498 DOI: 10.1016/j.healun.2014.01.065
Accession: 064420837
PDF emailed within 0-6 h: $19.90
Related References
Van Keer, J.; Derthoo, D.; Van Caenegem, O.; De Pauw, M.; Nellessen, E.; Duerinckx, N.; Droogne, W.; Vörös, G.áb.; Meyns, B.; Belmans, A.; Janssens, S.; Van Cleemput, J.; Vanhaecke, J. 2017: The CECARi Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: a Multicenter, Randomized Trial Journal of Transplantation 2017: 6347138Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Radegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Sigurdardottir, V.; Arora, S.; Dellgren, G.; Gullestad, L.; Christensen, S.B.; Just, C.; Selimovic, N.; Bollano, E.; Bartfay, S.-E.; Karason, K.; Roy, S.D.; Rexius, H.; Janssen, A.; Rosenberg, M.; Persson, L.; Kornhall, B.ör.; Ekmehag, B.ör.; Reitan, Öy.; Stueflotten, W.; Relbo, A.; Grov, I.; Erikstad, I.; Solberg, O.G.; Ragnarsson, A.; Aakhus, S.; Massey, R. 2014: Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14(8): 1828-1838
Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjær, H.; Rådegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.; Gullestad, l. 2015: Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial Journal of Heart and Lung Transplantation 34(4): S129-S130
Arora, S.; Andreassen, A.K.; Karason, K.; Gustafsson, F.; Eiskjær, H.; Bøtker, H.E.; Rådegran, G.ör.; Gude, E.; Ioanes, D.; Solbu, D.; Dellgren, G.ör.; Ueland, T.; Aukrust, P.ål.; Gullestad, L. 2018: Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in de Novo Heart Transplant Recipients CIRCULATION. Heart Failure 11(9): E004050
Arora, S.; Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Bøtker, H.E.; Rådegran, G.; Gude, E.; Ioanes, D.; Solbu, D.; Sigurdardottir, V.; Dellgren, G.; Erikstad, I.; Solberg, O.G.; Ueland, T.; Aukrust, P.; Gullestad, L.; Christensen, S.B.; Just, C.; Tram, E.M.; Mølbak, D.; Selimovic, N.; Bollano, E.; Bartfay, S.-E.; Karason, K.; Roy, S.D.; Rexius, H.; Janssen, A.; Rosenberg, M.; Persson, L.; Kornhall, B.ör.; Ekmehag, B.ör.; Reitan, Øy.; Stueflotten, W.; Relbo, A.; Grov, I.; Ragnarsson, A. 2015: The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in de Novo Recipients: One-Year Results of a Scandinavian Randomized Trial American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(7): 1967-1975
Uchida, J.; Iwai, T.; Kuwabara, N.; Kabei, K.; Nishide, S.; Yamasaki, T.; Naganuma, T.; Kumada, N.; Takemoto, Y.; Nakatanti, T. 2016: Clinical Experience of Late Conversion from Antimetabolites with Standard Exposure Calcineurin Inhibitors to Everolimus with Calcineurin Inhibitor Minimization in Stable Kidney Transplant Recipients with Good Renal Function Transplantation Proceedings 48(3): 775-780
Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Rådegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.; Gullestad, L. 2016: Everolimus Initiation with Early Calcineurin Inhibitor Withdrawal in de Novo Heart Transplant Recipients: Three-Year Results from the Randomized SCHEDULE Study American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16(4): 1238-1247
Maurer, J.R. 2011: Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial Yearbook of Pulmonary Disease 2011: 189-191
Gullestad, L.; Iversen, M.; Mortensen, S.-A.; Eiskjaer, H.; Riise, G.C.; Mared, L.; Bjørtuft, O.; Ekmehag, B.ör.; Jansson, K.; Simonsen, S.; Gude, E.; Rundqvist, B.; Fagertun, H.E.; Solbu, D.; Bergh, C.-H.åk. 2010: Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial Transplantation 89(7): 864-872
Gustafsson, F.; Andreassen, A.K.; Andersson, B.; Eiskjær, H.; Rådegran, G.ör.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.ör.; Gullestad, L. 2020: Everolimus Initiation with Early Calcineurin Inhibitor Withdrawal in de Novo Heart Transplant Recipients: Long-term Follow-up from the Randomized SCHEDULE Study Transplantation 104(1): 154-164
Murbraech, K.; Holdaas, H.; Massey, R.; Undset, L.H.; Aakhus, S. 2014: Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial Transplantation 97(2): 184-188
Watson, C.J.E.; Gimson, A.E.S.; Alexander, G.J.; Allison, M.E.D.; Gibbs, P.; Smith, J.C.; Palmer, C.R.; Bradley, J.A. 2007: A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13(12): 1694-1702
Murbraech, K.; Massey, R.; Undset, L.H.; Midtvedt, K.; Holdaas, H.; Aakhus, S. 2015: Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial Clinical Transplantation 29(8): 678-684
Castroagudín, J.F.; Molina, E.; Romero, R.; Otero, E.; Tomé, S.; Varo, E. 2009: Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 15(12): 1792-1797
De Simone, P.; Metselaar, H.J.; Fischer, L.; Dumortier, J.ér.ôm.; Boudjema, K.; Hardwigsen, J.; Rostaing, L.; De Carlis, L.; Saliba, F.; Nevens, F. 2009: Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 15(10): 1262-1269
Morales, J.; Fierro, A.; Benavente, D.; Zehnder, C.; Ferrario, M.; Contreras, L.; Herzog, C.; Buckel, E. 2007: Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria Transplantation Proceedings 39(3): 591-593
Andreassen, A. K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Raadegran, G.; Gude, E.; Solbu, D.; Sigurdardottir, V.; Dellgren, G.; Gullestad, L. 2013: Early calcineurin inhibitors avoidance improves renal function in de novo heart transplant recipients: The results of a randomized controlled trial (SCHEDULE trial) European Heart Journal 34(Suppl 1): 879-879
Gullestad, L.; Mortensen, S.-A.; Eiskjær, H.; Riise, G.C.; Mared, L.; Bjørtuft, O.; Ekmehag, B.ör.; Jansson, K.; Simonsen, S.; Gude, E.; Rundqvist, B.; Fagertun, H.E.; Solbu, D.; Iversen, M. 2010: Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial Transplantation 90(12): 1581-1589
Gullestad, L.; Eiskjaer, H.; Gustafsson, F.; Riise, G.C.; Karason, K.; Dellgren, G.ör.; Rådegran, G.ör.; Hansson, L.; Gude, E.; Bjørtuft, Øy.; Jansson, K.; Schultz, H.H.; Solbu, D.; Iversen, M. 2016: Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial Transplant International: Official Journal of the European Society for Organ Transplantation 29(7): 819-829
Nashan, B.; Schemmer, P.; Braun, F.; Dworak, M.; Wimmer, P.; Schlitt, H. 2015: Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial Trials 16: 118